5RG-30142-63677
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 975 / OR
- Registered
- 2021-12-29
- Relationship
- Child or adolescent in my care
- Guardian
- USR-32882-67973
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-07
Dose 1 — Pfizer-BioNTech
-
2021-12-29
Registered in v-safe
-
2021-12-29
Survey response — day 21, dose 1, dependentMedDRA: Cough — Feeling: GoodFree text: Mild intermittent dry cough. Began 1 week after vaccination. No other symptoms.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
- 2022-01-11
-
2022-01-30
Dose 2 — Pfizer-BioNTech
-
2022-01-31
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-02-01
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2022-02-02
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-02-03
- 2022-02-04
- 2022-02-05
- 2022-02-06
- 2022-02-13
- 2022-02-20
- 2022-02-27
- 2022-03-06
- 2022-03-13
- 2022-08-02
- 2023-01-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-07 | Pfizer-BioNTech | No |
| 2 | 2022-01-30 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 1, dependent
Symptoms: Mild intermittent dry cough. Began 1 week after vaccination. No other symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release